Insiders · PCRX

PCRX insider transactions

Pacira BioSciences Inc. (PCRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

PCRX insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Pacira BioSciences Inc., latest first. Follow anyone to get their next filing.

• Shawn CrossChief Financial Officer, since October 2024-$1.52M
• Jonathan SloninChief Medical Officer, since December 2023-$628K
• Lauren RikerSenior Vice President, Finance-$2.1M
• Samit HirawatDirector, since January 2026
• Christopher ChristieDirector
• Thomas G WiggansDirector, since June 2026
• Alethia YoungDirector, since October 2023
• Michael J. YangDirector, since October 2023+$25.8K
• Marcelo BigalDirector, since October 2023+$102K-$116K
• Mark FroimsonDirector+$16.2K-$123K
• Laura BregeDirector+$12.8K-$308K
• Kristen WilliamsChief Administrative Officer-$6.41M
• Mark A. KronenfeldDirector-$556K
• Brendan TeehanChief Commercial Officer, since January 2025
• Frank D. LeeChief Executive Officer, Director, since January 2024+$100K
• Abraham CeesayDirector, since October 2023-$64K
• Daryl GauglerChief Operating Officer, since May 2022-$328K
• Charles A. Reinhart IIIChief Financial Officer-$255K
• Paul J HastingsDirector-$607K
• Gary W PaceDirector-$5.87M
• Roy WinstonOfficer-$2.83M
• David M StackOfficer, Director-$7.56M
• Max ReinhardtOfficer-$3.5M
• Anthony MolloyOfficer, since December 2021-$2.36M
• Dennis McLoughlinOfficer-$327K
• Ronald J. Ellis Jr.Officer, since March 2023-$87.4K
• Charles Anthony LaranjeiraOfficer-$597K
• Yvonne GreenstreetDirector
• Longenecker John P PhdDirector-$863K
• Donald C. ManningOfficer-$307K
• Andreas WickiDirector-$17.5M

Recent Form 3, 4, and 5 filings for PCRX

• 5d
  Chief Financial Officer Cross Shawn covered exercise/tax liability with 9,540 shares, decreasing direct ownership by 9% to 95,801 units (SEC Form 4) (tax liability)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 30d
  Senior Vice President, Finance Riker Lauren sold $217,920 worth of shares (6,000 units at $36.32) as part of a pre-agreed trading plan (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 82d
  Chief Medical Officer Slonin Jonathan sold $70,619 worth of shares (3,040 units at $23.23) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 216,384 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 149d
  Director Hirawat Samit was granted 6,405 shares (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 149d
  Senior Vice President, Finance Riker Lauren sold $143,702 worth of shares (6,115 units at $23.50) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 62,284 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 149d
  SEC Form 4 filed by Director Wiggans Thomas G

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 149d
  Director Christie Christopher was granted 6,405 shares, increasing direct ownership by 38% to 23,059 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 149d
  Director Young Alethia was granted 6,405 shares, increasing direct ownership by 56% to 17,798 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 149d
  Director Yang Michael J. was granted 6,405 shares, increasing direct ownership by 48% to 19,798 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 149d
  Director Bigal Marcelo was granted 6,405 shares, increasing direct ownership by 56% to 17,798 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 149d
  Director Brege Laura was granted 6,405 shares, increasing direct ownership by 27% to 30,120 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 149d
  Director Froimson Mark was granted 6,405 shares, increasing direct ownership by 32% to 26,541 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 149d
  SEC Form 3 filed by new insider Wiggans Thomas G

  3 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 156d
  Senior Vice President, Finance Riker Lauren covered exercise/tax liability with 3,187 shares, decreasing direct ownership by 4% to 68,399 units (SEC Form 4) to satisfy withholding tax

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 156d
  Chief Medical Officer Slonin Jonathan covered exercise/tax liability with 4,728 shares, decreasing direct ownership by 2% to 218,912 units (SEC Form 4) to satisfy withholding obligation

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 156d
  Chief Administrative Officer Williams Kristen sold $228,468 worth of shares (10,259 units at $22.27) as part of a pre-agreed trading plan and covered exercise/tax liability with 8,528 shares, decreasing direct ownership by 10% to 167,062 units (SEC Form 4) to satisfy withholding obligation

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 198d
  Chief Financial Officer Cross Shawn exercised 12,941 shares at a strike of $16.45 and sold $325,596 worth of shares (12,941 units at $25.16) as part of a pre-agreed trading plan (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 200d
  SEC Form 4 filed by Cross Shawn

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 234d
  Amendment: SEC Form 4 filed by Kronenfeld Mark A.

  4/A - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 234d
  SEC Form 4 filed by Slonin Jonathan

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 234d
  SEC Form 4 filed by Froimson Mark

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 268d
  Chief Administrative Officer Williams Kristen was granted 54,546 shares, increasing direct ownership by 42% to 185,849 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 268d
  Chief Financial Officer Cross Shawn was granted 49,091 shares, increasing direct ownership by 87% to 105,341 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 268d
  Senior Vice President, Finance Riker Lauren was granted 19,273 shares, increasing direct ownership by 37% to 71,586 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 268d
  Chief Commercial Officer Teehan Brendan was granted 51,714 shares, increasing direct ownership by 105% to 100,934 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 268d
  Chief Medical Officer Slonin Jonathan was granted 54,546 shares, increasing direct ownership by 32% to 226,901 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 268d
  Chief Executive Officer Lee Frank D. was granted 261,818 shares, increasing direct ownership by 66% to 660,831 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 278d
  Senior Vice President, Finance Riker Lauren covered exercise/tax liability with 2,751 shares and sold $83,240 worth of shares (4,000 units at $20.81), decreasing direct ownership by 11% to 52,313 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 278d
  Chief Administrative Officer Williams Kristen covered exercise/tax liability with 17,134 shares and sold $269,703 worth of shares (13,137 units at $20.53), decreasing direct ownership by 19% to 131,303 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 278d
  Chief Commercial Officer Teehan Brendan covered exercise/tax liability with 5,182 shares, decreasing direct ownership by 10% to 49,220 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 278d
  Chief Medical Officer Slonin Jonathan covered exercise/tax liability with 6,168 shares, decreasing direct ownership by 3% to 172,355 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 278d
  Chief Executive Officer Lee Frank D. covered exercise/tax liability with 41,488 shares, decreasing direct ownership by 9% to 399,013 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 283d
  SEC Form 4 filed by Director Hirawat Samit

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 283d
  SEC Form 3 filed by new insider Hirawat Samit

  3 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 306d
  Chief Medical Officer Slonin Jonathan covered exercise/tax liability with 381 shares, decreasing direct ownership by 0.21% to 178,523 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 306d
  Senior Vice President, Finance Riker Lauren covered exercise/tax liability with 159 shares and sold $34,324 worth of shares (1,416 units at $24.24), decreasing direct ownership by 3% to 59,064 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 306d
  Chief Executive Officer Lee Frank D. covered exercise/tax liability with 9,272 shares, decreasing direct ownership by 2% to 440,501 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 306d
  Chief Commercial Officer Teehan Brendan was granted 402 shares, increasing direct ownership by 0.74% to 54,402 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 332d
  Chief Financial Officer Cross Shawn exercised 25,000 shares at a strike of $16.45 and sold $626,751 worth of shares (25,000 units at $25.07) (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 354d
  Chief Medical Officer Slonin Jonathan sold $95,396 worth of shares (3,960 units at $24.09), decreasing direct ownership by 2% to 178,367 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 360d
  Chief Financial Officer Cross Shawn sold $266,405 worth of shares (12,060 units at $22.09), decreasing direct ownership by 18% to 56,250 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 370d
  Chief Financial Officer Cross Shawn covered exercise/tax liability with 6,690 shares, decreasing direct ownership by 9% to 68,310 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 426d
  Director Ceesay Abraham sold $64,005 worth of shares (2,354 units at $27.19), decreasing direct ownership by 21% to 9,039 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 454d
  Director Bigal Marcelo sold $116,267 worth of shares (4,912 units at $23.67), decreasing direct ownership by 30% to 11,393 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 461d
  Chief Medical Officer Slonin Jonathan covered exercise/tax liability with 315 shares, decreasing direct ownership by 0.17% to 182,327 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 513d
  Director Kronenfeld Mark A. was granted 9,999 shares, increasing direct ownership by 40% to 34,901 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 513d
  Director Ceesay Abraham was granted 6,163 shares, increasing direct ownership by 118% to 11,393 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 513d
  Director Froimson Mark was granted 6,163 shares, increasing direct ownership by 43% to 20,636 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 513d
  Director Bigal Marcelo was granted 6,163 shares, increasing direct ownership by 61% to 16,305 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 513d
  Director Yang Michael J. was granted 6,163 shares, increasing direct ownership by 85% to 13,393 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 513d
  Director Christie Christopher was granted 6,163 shares, increasing direct ownership by 59% to 16,654 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 513d
  Director Young Alethia was granted 6,163 shares, increasing direct ownership by 118% to 11,393 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 513d
  Director Brege Laura was granted 6,163 shares, increasing direct ownership by 35% to 23,715 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 521d
  Senior Vice President, Finance Riker Lauren sold $146,208 worth of shares (5,578 units at $26.21) and covered exercise/tax liability with 3,374 shares, decreasing direct ownership by 13% to 59,564 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 521d
  Chief Administrative Officer Williams Kristen covered exercise/tax liability with 6,162 shares and sold $377,226 worth of shares (14,376 units at $26.24), decreasing direct ownership by 11% to 161,574 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 521d
  Chief Medical Officer Slonin Jonathan covered exercise/tax liability with 5,084 shares, decreasing direct ownership by 3% to 181,960 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 642d
  Chief Medical Officer Slonin Jonathan was granted 93,600 shares, increasing direct ownership by 100% to 187,044 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 642d
  Chief Administrative Officer Williams Kristen was granted 79,200 shares, increasing direct ownership by 77% to 182,112 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 642d
  Chief Executive Officer Lee Frank D. was granted 350,000 shares, increasing direct ownership by 356% to 448,409 units (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)
• 642d
  Chief Commercial Officer Teehan Brendan was granted 54,000 shares (SEC Form 4)

  4 - Pacira BioSciences, Inc. (0001396814) (Issuer)